Periodic Reporting for period 5 - TREGeneration (Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes)

TREGeneration is a clinical research consortium funded by the European Commission's Horizon 2020 Framework Programme for Research and Innovation. Our shared goal is to treat organ damage associated with Graft versus Host Disease (GVHD). Hematopoietic Stem Cell Transplantation...